Nav: Home

Keystone Symposia kicks off 2016-2017 series with Global Health Vaccines Conference in UK

October 12, 2016

SILVERTHORNE, CO - October 12, 2016 - Keystone Symposia will convene the first conference of its 2016-2017 season and the first in its 2016-17 Global Health Series - on "Translational Vaccinology for Global Health" - at the Park Plaza Riverbank in London, UK, October 25-29, 2016. The four-day open conference is part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, which has also funded travel awards for 43 investigators from 13 different low- and middle-income countries to attend. The sessions begin on Wednesday, October 25; the afternoon session that day will be held jointly with the closing session of the Grand Challenges conference for that program's grantees.

Scientific organizers of the Keystone Symposia conference are Drs. Christopher L. Karp of the Bill & Melinda Gates Foundation in Seattle, Washington, USA; Gagandeep Kang of Chrisian Medical College in India; and Rino Rappuoli of GlaxoSmithKline Vaccines in Siena, Italy.

The conference will focus on addressing the issues that make vaccine development and implementation unacceptably long, plus brainstorming ways to remove or mitigate these hurdles. Plenary sessions during the four days of the conference will feature presentations by speakers such as Peter D. Kwong of the National Institute of Allergy and Infectious Diseases at NIH; Sir Andrew J. McMichael of the Unviersity of Oxford; Anna P. Durbin of Johns Hopkins Bloomberg School of Public Health; Andrew J. Pollard of the University of Oxford; Rafi Ahmed of Emory University School of Medicine; and Beate Kampmann of Imperial College School of Medicine and MRC The Gambia. Supplementing these plenary sessions will be workshops with short talks showcasing the work of junior investigators and late-breaking research. The closing keynote address will be given by Dr. Chris Wilson of the Bill & Melinda Gates Foundation.

The conference will focus on the lessons learned from vaccine work covering a wide spectrum of diseases, including dengue, malaria, TB, typhoid and enteric fever, HPV, herpes zoster, and even cancer. Overall, it aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum." According to Dr. Jane Peterson, Keystone Symposia's Chief Executive Officer, "For the tenth consecutive year, we are very pleased to partner with the Bill & Melinda Gates Foundation in bringing a conference to the site of the annual Grand Challenges conference and hopefully engaging a wider scientific audience in tackling the greatest global health challenges of our time."

Beginning in 2006, Keystone Symposia has received grants from the Bill & Melinda Gates Foundation to fund conferences in the Keystone Symposia Global Health Series. This year for the first time, the Keystone Symposia Global Health Series has been expanded to include conferences beyond infectious diasease. In addition to 2017 conferences on tuberculosis, malaria, hemorraghic fever viruses and HIV, the 2016-2017 Series includes conferences on cancer immunotherapy, phytobiomes, and joint conferences on inflammation-driven cancer/the microbiome and diabetes/obesity.
-end-
About Keystone Symposia on Molecular and Cellular Biology

Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Summit County, Colorado, USA since 1990.

It will convene 60 conferences in the 2016-2017 season, the majority of which will take place between January and April 2017, on topics ranging from cancer and immunology to neuroscience and genomics. Registration fees are supplemented by generous financial support from corporate, foundation and individual donors as well as government grants.

More information on the vaccines conference can be found at http://www.keystonesymposia.org/16S1 and on the organization and its meetings at http://www.keystonesymposia.org and http://www.keystonesymposia.org/meetings, respectively. Details about the conferences in the Global Health Series are available at http://www.keystonesymposia.org/GlobalHealth.

Keystone Symposia on Molecular & Cellular Biology

Related Public Health Articles:

The Lancet Public Health: Ageism linked to poorer health in older people in England
Ageism may be linked with poorer health in older people in England, according to an observational study of over 7,500 people aged over 50 published in The Lancet Public Health journal.
Study: Public transportation use linked to better public health
Promoting robust public transportation systems may come with a bonus for public health -- lower obesity rates.
Bloomberg American Health Initiative releases special public health reports supplement
With US life expectancy now on the decline for two consecutive years, the Bloomberg American Health Initiative is releasing a supplement to Public Health Reports, the scholarly journal of the US Surgeon General.
Data does the heavy lifting: Encouraging new public health approaches to promote the health benefits of muscle-strengthening exercise (MSE)
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise (MSE) sessions a week, with nearly 60 percent of the population doing no MSE at all.
The Lancet Public Health: Moderate carbohydrate intake may be best for health
Low-carb diets that replace carbohydrates with proteins and fats from plant sources associated with lower risk of mortality compared to those that replace carbohydrates with proteins and fat from animal sources.
Mass. public safety, public health agencies collaborate to address the opioid epidemic
A new study shows that public health and public safety agencies established local, collaborative programs in Massachusetts to connect overdose survivors and their personal networks with addiction treatment, harm reduction, and other community support services following a non-fatal overdose.
Cyber attacks can threaten public health
Gordon and Landman have authored a Perspective piece in the New England Journal of Medicine that addresses the growing threat of attacks on information systems and the potential implications on public health.
Public health guidelines aim to lower health risks of cannabis use
Canada's Lower-Risk Cannabis Use Guidelines, released today with the endorsement of key medical and public health organizations, provide 10 science-based recommendations to enable cannabis users to reduce their health risks.
Study clusters health behavior groups to broaden public health interventions
A new study led by a University of Kansas researcher has used national health statistics and identified how to cluster seven health behavior groups based on smoking status, alcohol use, physical activity, physician visits and flu vaccination are associated with mortality.
Public health experts celebrate 30 years of CDC's prevention research solutions for communities with health disparities
It has been 30 years since CDC created the Prevention Research Centers (PRC) Program, currently a network of 26 academic institutions across the US dedicated to moving new discoveries into the communities that need them.
More Public Health News and Public Health Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#544 Prosperity Without Growth
The societies we live in are organised around growth, objects, and driving forward a constantly expanding economy as benchmarks of success and prosperity. But this growing consumption at all costs is at odds with our understanding of what our planet can support. How do we lower the environmental impact of economic activity? How do we redefine success and prosperity separate from GDP, which politicians and governments have focused on for decades? We speak with ecological economist Tim Jackson, Professor of Sustainable Development at the University of Surrey, Director of the Centre for the Understanding of Sustainable Propserity, and author of...
Now Playing: Radiolab

An Announcement from Radiolab